McDonald's Corp (MCD) 97.44 $MCD Don't Follow Warren

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
McDonald's Corp (MCD) 97.44 $MCD

Don't Follow Warren Buffett When It Comes To Food Stocks
Jeremy Bowman, The Motley Fool - Motley Fool - Tue Mar 31, 2:23PM CDT
Warren Buffett cannonballed through the food industry once again this past week, orchestrating a merger of Heinz and  Kraft Foods  to create the world's third-largest food company. Buffett's Berkshire Hathaway  conglomerate and partner 3G...
KO: 40.55 (+0.04), CMG: 650.54 (-4.82), MCD: 97.44 (-0.44), KRFT: 87.11 (-3.50)

3 Promising Restaurant Stocks Under $10
Rick Munarriz, The Motley Fool - Motley Fool - Tue Mar 31, 12:48PM CDT
Source: Ignite Restaurant Group.  Restaurant stocks are on fire these days, but let's not assume that all of the growing chains are holding up on Wall Street. In fact, there are a couple of intriguing eateries trading in the single digits. ...
IRG: 4.85 (-0.08), ARCO: 4.93 (-0.05), MCD: 97.44 (-0.44), TAST: 8.29 (-0.08)

Short Sellers May Be Interested In McDonald's
Stock Traders Daily - at Seeking Alpha - Tue Mar 31, 12:07PM CDT

MCD: 97.44 (-0.44)

Dunkin' to Serve Cage-Free Eggs for Health Aware Guests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 31, 11:40AM CDT
Dunkin' Brands Group, Inc. (DNKN) announced, in partnership with Humane Society of the United States (HSUS), that 10% of all eggs used for its breakfast sandwiches in the U.S. will be cage-free by the end of 2016.
DNKN: 47.56 (-0.04), PNRA: 159.99 (+0.46), CMG: 650.54 (-4.82), MCD: 97.44 (-0.44)

11 Safe High-Yield Dividend Stocks for Times of Volatility and Uncertainty
at The Street - Tue Mar 31, 11:37AM CDT
Have you prepared for the next bear market with these 11 high-yield stocks that have historically outperformed the S&P 500 in bear markets?
KO: 40.55 (+0.04), ED: 61.00 (+0.21), KMB: 107.11 (-0.63), SYY: 37.73 (-0.53), SPB: 89.56 (-1.40), MO: 50.02 (-0.51), SO: 44.28 (-0.05), K: 65.95 (+0.45), T: 32.65 (-0.32), MCD: 97.44 (-0.44), PG: 81.94 (-0.78), BRK.B: 144.32 (-1.66), VZ: 48.63 (-0.49), BRK.A: 217,500.00 (-2,200.00), GIS: 56.60 (+0.25)

McDonald’s (MCD) Stock Down Today as Restaurant to Test All-Day Breakfast Menu
at The Street - Tue Mar 31, 8:54AM CDT
McDonald’s (MCD) stock is lower today as the fast food chain is going to begin testing an all-day breakfast menu in San Diego next month.
MCD: 97.44 (-0.44)

McDonald's to Test All-Day Breakfast, Will Sales Improve? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 31, 8:30AM CDT
McDonald's Corporation (MCD) will reportedly begin testing of breakfast items throughout the day at some of its outlets in the San Diego area beginning April.
JACK: 95.92 (-1.12), DNKN: 47.56 (-0.04), MCD: 97.44 (-0.44), YUM: 78.72 (-0.69)

Wall Street Breakfast: Euro Heads For Biggest Quarterly Fall On Record
Wall Street Breakfast - at Seeking Alpha - Tue Mar 31, 5:30AM CDT

TSLA: 188.77 (-1.80), AMZN: 372.10 (-2.49), HLF: 42.76 (+0.04), BX: 38.89 (+0.48), PHG: 28.34 (-0.43), FUR: 16.32 (-0.03), SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), IBM: 160.50 (-2.17), MCD: 97.44 (-0.44), AIG: 54.79 (+0.11), EPD: 32.93 (+0.02)

McD's to test all-day breakfast
at Investor's Business Daily - Mon Mar 30, 5:54PM CDT
The fast-food giant said that it plans to try out an all-day breakfast offering in certain San Diego locations, beginning in April. The McDonald's (MCD) test menu will include some breakfast sandwiches and hash browns, among other items. The company...
MCD: 97.44 (-0.44), YUM: 78.72 (-0.69)

Here's What Else McDonald's Should Do Besides Offer All-Day Breakfast
at The Street - Mon Mar 30, 2:57PM CDT
McDonald's will be testing all-day breakfast in one location next month, but the chain should also consider a couple of other moves to revive flagging sales.
QSR: 38.41 (-0.71), SHAK: 50.05 (+0.43), CMG: 650.54 (-4.82), MCD: 97.44 (-0.44), YUM: 78.72 (-0.69)

McDonald's rolling out changes on both sides of the pond
Seeking Alpha - at Seeking Alpha - Mon Mar 30, 2:07PM CDT

MCD: 97.44 (-0.44)


McDonald's to test all-day breakfast beginning in April
AP - Mon Mar 30, 12:58PM CDT
NEW YORK (AP) — A McMuffin for dinner? It might happen, as McDonald's plans to test an all-day breakfast at some locations in the San Diego area starting next month.
MCD: 97.44 (-0.44)

The Argument Against The REIT Is McWrong. Here Is Why It Works For McDonald's.
ColoradoWealthManagementFund - at Seeking Alpha - Mon Mar 30, 12:33PM CDT

MCD: 97.44 (-0.44)

Wake Me Up When The Second Half Of 2015 Begins
Bret Jensen - at Seeking Alpha - Mon Mar 30, 10:57AM CDT

TSLA: 188.77 (-1.80), SHAK: 50.05 (+0.43), SPY: 206.43 (-1.82), QQQ: 105.60 (-1.13), DIA: 177.58 (-1.81), MCD: 97.44 (-0.44), IWM: 124.37 (-0.40)

Why Wendy's May Be One Of McDonald's Most Overlooked Problems
Michael Carter - at Seeking Alpha - Mon Mar 30, 10:15AM CDT

MCD: 97.44 (-0.44), WEN: 10.90 (-0.24)

All-day breakfast to be tested at McDonald's
Seeking Alpha - at Seeking Alpha - Mon Mar 30, 8:23AM CDT

MCD: 97.44 (-0.44)

Nonfarm Payrolls Will Be Closely Watched - Cramer's Mad Money (3/27/15)
SA Editor Mohit Manghnani - Seeking Alpha - Mon Mar 30, 6:40AM CDT
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Friday, March 27. There wasn't much positive news from the stock market last week, apart from the Kraft (NASDAQ: KRFT ) merger. In the coming week, there is only going...
BIIB: 422.24 (-9.38), GE: 24.81 (-0.31), PCYC: 255.95 (-0.48), MON: 112.54 (-0.84), FRPT: 19.43 (-0.62), HON: 104.31 (-0.60), KRFT: 87.11 (-3.50), INTC: 31.27 (-0.19), BWLD: 181.24 (-1.73), AIR: 30.70 (-0.76), KMX: 69.01 (-0.21), JACK: 95.92 (-1.12), YHOO: 44.44 (-0.51), SONC: 31.70 (-0.59), CMG: 650.54 (-4.82), ABBV: 58.54 (+0.30), REGN: 451.48 (-8.30), UNP: 108.31 (-1.78), DK: 39.75 (-0.16), YUM: 78.72 (-0.69), MU: 27.13 (+0.45), SWKS: 98.29 (-1.84), AMGN: 159.85 (-4.45), NXPI: 100.36 (-2.07), BA: 150.08 (-2.62), PLKI: 59.82 (-0.92), FRGI: 61.00 (-1.03), HAIN: 64.05 (-0.23), WWAV: 44.34 (-0.30), ZOES: 33.29 (+0.37), QRVO: 79.70 (-1.70), CBRL: 152.14 (-0.65), CNI: 66.87 (+0.64), NDLS: 17.44 (-0.10), MCD: 97.44 (-0.44), AVGO: 126.98 (-3.57)

3 Retirement Stocks Wall Street Is Wrong About
Dan Dzombak, Dan Caplinger, and Asit Sharma, The Motley Fool - Motley Fool - Sun Mar 29, 9:17AM CDT
Sometimes the stocks that investors hold in their retirement savings accounts get beaten down for no good reason. With that in mind, we asked our Motley Fool contributors which retirement stocks they think Wall Street is wrong about. Here's what they...
KO: 40.55 (+0.04), IBM: 160.50 (-2.17), MCD: 97.44 (-0.44)

The Coca-Cola Co: Why CEO Muhtar Kent Is Doubling Down on Soda
Jeremy Bowman, The Motley Fool - Motley Fool - Sun Mar 29, 8:08AM CDT
Coca-Cola is facing a Coca-nundrum. Soda consumption has been falling in the U.S. for more than a decade as health and obesity concerns have stunted demand for sugary carbonated drinks. Even in developing markets, demand for fizzy beverages is...
KO: 40.55 (+0.04), MNST: 138.39 (-2.05), GMCR: 111.73 (-2.23), MCD: 97.44 (-0.44), CPB: 46.55 (+0.10), PEP: 95.62 (-0.90), K: 65.95 (+0.45)

Dividend Achievers Top 20 Hits The Mark, Again
Dale Roberts - at Seeking Alpha - Sat Mar 28, 1:11AM CDT

MMM: 164.95 (-1.10), GE: 24.81 (-0.31), NKE: 100.33 (-0.56), UTX: 117.20 (-1.63), VIG: 80.47 (-0.77), WMT: 82.25 (-0.28), XOM: 85.00 (-0.63), PEP: 95.62 (-0.90), JNJ: 100.60 (-0.95), T: 32.65 (-0.32), SPY: 206.43 (-1.82), IBM: 160.50 (-2.17), QCOM: 69.34 (+0.46), KO: 40.55 (+0.04), ABT: 46.33 (-0.75), RSP: 81.05 (-0.56), COP: 62.26 (-1.74), WFC: 54.40 (-0.37), VOO: 189.20 (-1.68), TXN: 57.18 (-0.82), MCD: 97.44 (-0.44), CVS: 103.21 (-0.62), AIG: 54.79 (+0.11), PG: 81.94 (-0.78), CVX: 104.98 (-1.92)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 10

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 14

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 9

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 11

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 14

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

Replay Sports Cards Revolutionizes the Trading Card Industry

Updated Category News Views 288

Replay Sports Cards Capitalizes on Trading Card Opportunities Trading cards are undergoing a radical transformation; what was once seen as a childhood pastime is now a robust business venture. The trading card market is expected to expand exponentially, with estimated sales skyrocketing from $14.9 billion in 2023 to an incredible $52.1 billion by 2034. This surge speaks...

Continue Reading
Moca Network's AIR Shop Revolutionizes Event Ticketing Experience

Updated Category News Views 159

Moca Network's AIR Shop Revolutionizes Event Ticketing Experience Fans can now enjoy exciting new opportunities as Moca Network introduces AIR Shop Tickets, a remarkable platform that offers over 40 million tickets for concerts, sports, theater performances, and various live events. With this innovation, fans have a unique chance to earn up to 10% back on ticket purchases...

Continue Reading
Cincinnati Children's and MultiCare: Boosting Heart Care Access

Updated Category News Views 204

Big Changes for Pediatric Heart Care in the PNW Ever find yourself stuck between a rock and a hard place when it comes to healthcare options for your kids? I swear, like clockwork, every time I think about the state of pediatric care, it sends me down memory lane—could be the dot-com bust vibes, you know? Anyway, Cincinnati Children's Hospital is teaming up with...

Continue Reading
Immuneering Gains Orphan Drug Status for Groundbreaking Cancer Therapy

Updated Category News Views 117

Immuneering Corporation's Orphan Drug Designation Immuneering Corporation (NASDAQ:IMRX), a pioneering biotechnology firm in the oncology space, is making headlines with the recent designation of its drug candidate, IMM-1-104, as an orphan drug by the U.S. Food and Drug Administration (FDA). This recognition is a crucial step in the development of treatments aimed at rare...

Continue Reading
Applied Optoelectronics Unveils New Employee Equity Grants

Updated Category News Views 203

Applied Optoelectronics Introduces New Equity Grants for Employees In an exciting development, Applied Optoelectronics, Inc. (NASDAQ: AAOI) has announced that its board's Compensation Committee has awarded equity grants to new employees under their inducement plan. This initiative involves granting 11,860 shares of common stock to five new team members, with a specific...

Continue Reading